JP2005206602A5 - - Google Patents

Download PDF

Info

Publication number
JP2005206602A5
JP2005206602A5 JP2005013897A JP2005013897A JP2005206602A5 JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5 JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5
Authority
JP
Japan
Prior art keywords
antibody
arginine
producing
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005013897A
Other languages
English (en)
Japanese (ja)
Other versions
JP4826995B2 (ja
JP2005206602A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005206602A publication Critical patent/JP2005206602A/ja
Publication of JP2005206602A5 publication Critical patent/JP2005206602A5/ja
Application granted granted Critical
Publication of JP4826995B2 publication Critical patent/JP4826995B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2005013897A 2004-01-21 2005-01-21 抗体の変質を防止する精製方法 Expired - Lifetime JP4826995B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53750304P 2004-01-21 2004-01-21
US60/537503 2004-01-21
US63140704P 2004-11-30 2004-11-30
US60/631407 2004-11-30

Publications (3)

Publication Number Publication Date
JP2005206602A JP2005206602A (ja) 2005-08-04
JP2005206602A5 true JP2005206602A5 (enExample) 2008-03-06
JP4826995B2 JP4826995B2 (ja) 2011-11-30

Family

ID=34753090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005013897A Expired - Lifetime JP4826995B2 (ja) 2004-01-21 2005-01-21 抗体の変質を防止する精製方法

Country Status (5)

Country Link
US (3) US8084032B2 (enExample)
EP (1) EP1568710B1 (enExample)
JP (1) JP4826995B2 (enExample)
CN (1) CN1680426B (enExample)
DE (1) DE602005018406D1 (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
EP1698637B1 (en) * 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
EP1877581B1 (en) * 2005-05-06 2012-03-28 Gen-Probe Incorporated Methods and products for nucleic acid target capture
MY169472A (en) * 2006-07-14 2019-04-12 Genentech Inc Refolding of recombinant proteins
JP5386354B2 (ja) * 2006-09-08 2014-01-15 ワイス・エルエルシー アフィニティークロマトグラフィーを使用するタンパク質精製におけるアルギニン洗浄
MX345141B (es) 2006-09-13 2017-01-18 Abbvie Inc * Mejoras de cultivos celulares.
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2089429B1 (en) * 2006-10-19 2014-11-26 Janssen Biotech, Inc. Process for preparing unaggregated antibody fc domains
US8669045B2 (en) * 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
WO2009136568A1 (ja) * 2008-05-08 2009-11-12 味の素株式会社 タンパク質のリフォールディング方法
JP4542172B2 (ja) * 2008-05-19 2010-09-08 日本電波工業株式会社 感知装置及び感知方法
WO2010019493A1 (en) * 2008-08-14 2010-02-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
CA2738499A1 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
JP2011041475A (ja) * 2009-08-19 2011-03-03 Asahi Kasei Medical Co Ltd 抗体製造方法
WO2011073389A1 (en) * 2009-12-18 2011-06-23 Novartis Ag Wash solution and method for affinity chromatography
CA2784959C (en) 2010-01-22 2018-06-26 Boehringer Ingelheim International Gmbh Chromatographic method for purifying fc-containing proteins
ES2544284T3 (es) 2010-02-26 2015-08-28 Ajinomoto Co., Inc. Composición que inactiva virus que contiene un compuesto de bajo peso molecular y arginina
US20130096284A1 (en) * 2010-06-21 2013-04-18 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
JP6366502B2 (ja) * 2011-06-01 2018-08-01 ノバルティス アーゲー アフィニティクロマトグラフィーのための、洗浄溶液および方法
EP2725104B1 (en) 2011-06-23 2019-08-21 Ajinomoto Co., Inc. Method for preparing a polymeric protein composed of a monomeric protein produced by fusing a protein having immunoglobulin fold structure to a protein capable of serving as subunit structure
JPWO2014003137A1 (ja) * 2012-06-27 2016-06-02 旭化成メディカル株式会社 高アフィニティー抗体、及びその製造方法
WO2014054744A1 (ja) * 2012-10-03 2014-04-10 協和発酵キリン株式会社 培養液にアミノ酸を添加することによるポリペプチドの還元防止方法
KR102219672B1 (ko) 2013-06-17 2021-02-25 드 슈타트 데르 네덜란덴, 베르테겐부어디그트 두어 드 미니스터 반 베이웨이에스, 미니스테리 반 폭스겐트존하이트, 벨지인 엔 스포츠 바이러스 성분의 어그리게이션을 저해하는 방법
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
CN105273041A (zh) * 2014-07-08 2016-01-27 上海中信国健药业股份有限公司 一种蛋白质亲和层析洗脱方法
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
IL287947B2 (en) 2014-10-23 2024-08-01 Amgen Inc Viscosity reduction of pharmaceutical preparations
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3374371A4 (en) * 2015-11-09 2019-12-11 University of Notre Dame SMALL MOLECULE AFFINITY MEMBRANE PURIFICATION SYSTEMS AND USE THEREOF
HRP20160086A2 (hr) 2016-01-27 2017-08-11 Sveučilište u Zagrebu Eluens za imunoafinitetnu kromatografiju virusa i proteina
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
JP6987424B2 (ja) 2016-05-11 2022-01-05 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを洗浄および/または消毒する方法
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
MX392628B (es) 2016-07-25 2025-03-24 Cephalon Inc Amortiguador de lavado de cromatografia de afinidad.
US11020686B2 (en) 2016-08-16 2021-06-01 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
JP7102401B2 (ja) 2016-10-25 2022-07-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド クロマトグラフィーデータ解析のための方法およびシステム
JP7377596B2 (ja) 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
JP6897761B2 (ja) * 2017-04-07 2021-07-07 コニカミノルタ株式会社 タンパク質修飾蛍光体集積粒子の精製物を製造する方法、蛍光染色液の製造方法、タンパク質修飾蛍光体集積粒子の精製物、蛍光染色液およびタンパク質修飾蛍光体集積粒子精製用フィルター
KR102798879B1 (ko) 2017-09-19 2025-04-30 리제너론 파아마슈티컬스, 인크. 입자 형성을 감소시키는 방법 및 그것에 의해 형성된 조성물
JP7158015B2 (ja) * 2017-11-09 2022-10-21 国立研究開発法人産業技術総合研究所 ポリペプチドの凝集化抑制方法
CN111902720B (zh) 2018-03-21 2025-02-07 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
TW202448568A (zh) 2018-07-02 2024-12-16 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
BR112021023542A2 (pt) 2019-08-02 2022-03-22 UCB Biopharma SRL Métodos para purificar anticorpos
WO2021064066A1 (en) * 2019-10-04 2021-04-08 Merck Patent Gmbh Elution of monoclonal antibodies in protein a affinity chromatography
CN112898413A (zh) * 2021-04-07 2021-06-04 杭州奕安济世生物药业有限公司 采用亲和层析纯化减少抗体聚集的方法
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323567C (en) 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
JPH02273194A (ja) 1989-04-14 1990-11-07 Sumitomo Chem Co Ltd ヒトモノクローナル抗体の安定な精製法
AU5292693A (en) 1992-10-02 1994-04-26 General Hospital Corporation, The Affinity purification methods involving amino acid mimetics as elution reagents
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US7223848B2 (en) 2001-06-05 2007-05-29 Genetics Institute, Llc Methods for purifying Fc-containing proteins
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
EP1698637B1 (en) 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
WO2009136568A1 (ja) 2008-05-08 2009-11-12 味の素株式会社 タンパク質のリフォールディング方法

Similar Documents

Publication Publication Date Title
JP2005206602A5 (enExample)
WO2006138553A3 (en) Methods of purifying fc region containing proteins
DE602005014969D1 (de) Verfahren zur aufreinigung von albumin-konjugaten
NZ587511A (en) Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
EP1568710A3 (en) Antibody purification method
JP2012018171A5 (enExample)
EP1477800A4 (en) Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid
WO2009139601A3 (en) Method and affinity column for purifying proteins
ATE417056T1 (de) Verfahren zur proteinreinigung
DE602004026500D1 (de) Verfahren zur Markierung phosphorylierten Peptiden, Komplexverbindunger, Verfahren zu deren Herstellung und Zwischenprodukte
EP1780537A4 (en) PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
Acikara et al. Affinity chromatography and importance in drug discovery
WO2004008942A3 (en) Rapid process for purification and concentration of plasmin
ATE541037T1 (de) Verfahren zur trennung und reinigung von nukleinsäure
JP2009543099A5 (enExample)
JP2009518428A5 (enExample)
JP2009133739A5 (enExample)
RU2004103098A (ru) Способ прижизненного определения острой фазы стафилококкового среднего отита в эксперименте
Van Essche et al. VENTURE™ A-High Performance Analytical Column for the Purification of Antibodies
TW200720655A (en) ELISA kit for diagnosting infectious bursal disease (IBD) and method using the same
JP2005104906A (ja) 銅結合性ペプチド及びその使用
ZA200704836B (en) Adsorption agent, in particular for adsorbing proteins from liquids containing protein
TH160179A (th) การทำไอดิลโรเนต-2-ซัลฟาเตสให้บริสุทธิ์